Oncostatin M promotes osteogenesis and suppresses adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells

Journal of Cellular Biochemistry

Volumn 101, Issue 5, 2007, Pages 1238-1251

  Hae, Young Song ^a   Eun, Su Jeon ^a   Jung, Il Kim ^b   Jin, Sup Jung ^a   Jae, Ho Kim ^a,b  

^a Pusan National University   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

Author keywords

Adipocytes; JAK2; JAK3; Mesenchymal stem cells; OSM; Osteoblasts

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 HYDROXYANILINO) 6,7 DIMETHOXYQUINAZOLINE; ALKALINE PHOSPHATASE; JANUS KINASE 2; JANUS KINASE 3; JANUS KINASE 3 INHIBITOR; JANUS KINASE INHIBITOR; LIPID; LIPOPROTEIN LIPASE; MITOGEN ACTIVATED PROTEIN KINASE; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; ONCOSTATIN M; OSTEOCALCIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANSCRIPTION FACTOR RUNX2;

ADIPOGENESIS; ADIPOSE TISSUE; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ANALYSIS; ENZYME INHIBITION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MINERALIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADIPOGENESIS; ADIPOSE TISSUE; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-6; JANUS KINASE 2; JANUS KINASE 3; MESENCHYMAL STEM CELLS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; ONCOSTATIN M; OSTEOBLASTS; OSTEOGENESIS; TIME FACTORS;

EID: 34547855102     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21245     Document Type: Article

References (29)

1. Aubert J, Dessolin S, Belmonte N, Li M, McKenzie FR, Staccini L, Villageois P, Barhanin B, Vernallis A, Smith AG, Ailhaud G, Dani C. 1999. Leukemia inhibitory factor and its receptor promote adipocyte differentiation via the mitogen-activated protein kinase cascade. J Biol Chem 274:24965-24972.
2. Barry FP, Murphy JM. 2004. Mesenchymal stem cells: Clinical applications and biological characterization. Int J Biochem Cell Biol 36:568-584.
3. Bellido T, Borba VZ, Roberson P, Manolagas SC. 1997. Activation of the Janus kinase/STAT (signal transducer and activator of transcription) signal transduction pathway by interleukin-6-type cytokines promotes osteoblast differentiation. Endocrinology 138:3666-3676.
4. Bellido T, O'Brien CA, Roberson PK, Manolagas SC. 1998. Transcriptional activation of the p21(WAF1,CIP1,SDI1) gene by interleukin-6 type cytokines. A prerequisite for their pro-differentiating and anti-apoptotic effects on human osteoblastic cells. J Biol Chem 273:21137-21144.
5. Beresford JN, Bennett JH, Devlin C, Leboy PS, Owen ME. 1992. Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J Cell Sci 102(Pt 2):341-351.
6. Caplan AI. 1991. Mesenchymal stem cells. J Orthop Res 9:641-650.
7. Chan GK, Duque G. 2002. Age-related bone loss: Old bone, new facts. Gerontology 48:62-71.
8. Chipoy C, Berreur M, Couillaud S, Pradal G, Vallette F, Colombeix C, Redini F, Heymann D, Blanchard F. 2004. Downregulation of osteoblast markers and induction of the glial fibrillary acidic protein by oncostatin M in osteosarcoma cells require PKCdelta and STAT3. J Bone Miner Res 19:1850-1861.
9. Dagoneau N, Scheffer D, Huber C, Al Gazali LI, Di Rocco M, Godard A, Martinovic J, Raas-Rothschild A, Sigaudy S, Unger S, Nicole S, Fontaine B, Taupin JL, Moreau JF, Superti-Furga A, Le Merrer M, Bonaventure J, Munnich A, Legeai-Mallet L, Cormier-Daire V. 2004. Null leukemia inhibitory factor receptor (LIFR) mutations in StuveWiedemann/Schwartz-Jampel type 2 syndrome. Am J Hum Genet 74:298-305.
10. Gimble JM, Wanker F, Wang CS, Bass H, Wu X, Kelly K, Yancopoulos GD, Hill MR. 1994. Regulation of bone marrow stromal cell differentiation by cytokines whose receptors share the gp130 protein. J Cell Biochem 54:122-133.
11. Gomez-Lechon MJ. 1999. Oncostatin M: Signal transduction and biological activity. Life Sci 65:2019-2030.
12. Heymann D, Rousselle AV. 2000. gp130 Cytokine family and bone cells. Cytokine 12:1455-1468.
13. Kamimura D, Ishihara K, Hirano T. 2003. IL-6 signal transduction and its physiological roles: The signal orchestration model. Rev Physiol Biochem Pharmacol 149:1-38.
14. Kang YJ, Jeon ES, Song HY, Woo JS, Jung JS, Kim YK, Kim JH. 2005. Role of c-Jun N-terminal kinase in the PDGF-induced proliferation and migration of human adipose tissue-derived mesenchymal stem cells. J Cell Biochem 95:1135-1145.
15. Lee RH, Kim B, Choi I, Kim H, Choi HS, Suh K, Bae YC, Jung JS. 2004. Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 14:311-324.
16. Malaval L, Liu F, Vernallis AB, Aubin JE. 2005. GP130/OSMR is the only LIF/IL-6 family receptor complex to promote osteoblast differentiation of calvaria progenitors. J Cell Physiol 204:585-593.
17. Malik N, Haugen HS, Modrell B, Shoyab M, Clegg CH. 1995. Developmental abnormalities in mice transgenic for bovine oncostatin M. Mol Cell Biol 15:2349-2358.
18. Meunier P, Aaron J, Edouard C, Vignon G. 1971. Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies. Clin Orthop Relat Res 80:147-154.
19. Novikoff AB, Novikoff PM, Rosen OM, Rubin CS. 1980. Organelle relationships in cultured 3T3-L1 preadipocytes. J Cell Biol 87:180-196.
20. Nuttall ME, Gimble JM. 2000. Is there a therapeutic opportunity to either prevent or treat osteopenic disorders by inhibiting marrow adipogenesis? Bone 27:177-184.
21. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
22. Prockop DJ. 1997. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71-74.
23. Shin HI, Divieti P, Sims NA, Kobayashi T, Miao D, Karaplis AC, Baron R, Bringhurst R, Kronenberg HM. 2004. Gp130-mediated signaling is necessary for normal osteoblastic function in vivo and in vitro. Endocrinology 145:1376-1385.
24. Short B, Brouard N, Occhiodoro-Scott T, Ramakrishnan A, Simmons PJ. 2003. Mesenchymal stem cells. Arch Med Res 34:565-571.
25. Song HY, Jeon ES, Jung JS, Kim JH. 2005. Oncostatin M induces proliferation of human adipose tissue-derived mesenchymal stem cells. Int J Biochem Cell Biol 37:2357-2365.
26. Taguchi Y, Yamamoto M, Yamate T, Lin SC, Mocharla H, DeTogni P, Nakayama N, Boyce BF, Abe E, Manolagas SC. 1998. Interleukin-6-type cytokines stimulate mesenchymal progenitor differentiation toward the osteoblastic lineage. Proc Assoc Am Physicians 110:559-574.
27. Tanaka M, Miyajima A. 2003. Oncostatin M, a multifunctional cytokine. Rev Physiol Biochem Pharmacol 149:39-52.
28. Tontonoz P, Hu E, Spiegelman BM. 1994. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 79:1147-1156.
29. Ziros PG, Gil AP, Georgakopoulos T, Habeos I, Kletsas D, Basdra EK, Papavassiliou AG. 2002. The bone-specific transcriptional regulator Cbfa1 is a target of mechanical signals in osteoblastic cells. J Biol Chem 277:23934-23941.